Genetic Collection Protocol
Launched by ARBOR RESEARCH COLLABORATIVE FOR HEALTH · Mar 8, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Genetic Collection Protocol is a study looking into liver diseases by collecting samples of blood or saliva from participants. The main goal is to gather and store DNA, which will be used for ongoing and future research related to these conditions. This study is currently recruiting participants, including children aged 1 to 9131 and their biological parents, to help advance our understanding of liver diseases.
To participate, children must have previously been part of specific studies (like PROBE, BASIC, LOGIC, or MITOHEP) and still be under care at the clinical site. Their biological parents can also take part if they haven't previously provided a DNA sample. Participants will only need to provide a sample once, and the process is straightforward. It's important to note that some individuals, such as those who have passed away or cannot be contacted, are not eligible for the study. This research is crucial for improving treatment and care for liver diseases in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • For Child Participants
- • 1. Previous enrollment in PROBE, BASIC, LOGIC, or MITOHEP
- • 2. Exited from one of the aforementioned studies.
- • 3. Consent for DNA sample collection obtained during enrollment during enrollment to one of the aforementioned studies but sample not previously collected.
- • 4. Still followed at the clinical site.
- • For Biological Parent Participants
- • 1. Biological parents of previously consented child participant without collection of a parental DNA biospecimen.
- • 2. Child still followed at the clinical site.
- Exclusion Criteria:
- • For Child Participants
- • 1. Participant is deceased
- • 2. Participant exited from prior study due to violating eligibility criteria
- • 3. Participant cannot be contacted
- • For Biological Parent Participants
- • 1. Non-biological parent
- • 2. Child DNA was not previously collected and will not be collected in this study
About Arbor Research Collaborative For Health
Arbor Research Collaborative for Health is a non-profit research organization dedicated to improving health outcomes through innovative clinical research and data analysis. With a focus on advancing medical knowledge and patient care, Arbor Research collaborates with academic institutions, healthcare providers, and industry partners to conduct rigorous studies in various fields, including nephrology, infectious diseases, and health services research. Their commitment to scientific excellence and community engagement drives their mission to translate research findings into actionable solutions that enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Seattle, Washington, United States
Indianapolis, Indiana, United States
Philadelphia, Pennsylvania, United States
Los Angeles, California, United States
Pittsburgh, Pennsylvania, United States
Toronto, Ontario, Canada
Cincinnati, Ohio, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Salt Lake City, Utah, United States
San Francisco, California, United States
Houston, Texas, United States
Toronto, Ontario, Canada
Houston, Texas, United States
Patients applied
Trial Officials
Ed Doo, MD
Study Director
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Averell Sherker, MD
Study Director
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
John Magee, MD
Principal Investigator
University of Michigan
Lisa Henn, PhD
Principal Investigator
Arbor Research Collaborative for Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials